Peer-reviewedCC BYThe Journal of clinical investigation
Selective estrogen receptor degraders and their effect on the breast cancer immune microenvironment
Related
- A conditional, myeloid-cell specific estrogen receptor α deletion reprograms the liver immune microenvironment and impedes the growth of colon carcinoma liver metastases
- Tamoxifen and Doxorubicin Synergistically Target Estrogen Receptor beta-Mutant p53-p73 Axis, a Therapeutically Actionable Vulnerability in Triple Negative Breast Cancer
- Estradiol Modulates Cytotoxic Responses to Topoisomerase II Targeting Agents in Estrogen Receptor Positive Breast Cancer Cells
- Impact of Trastuzumab and Pertuzumab on HER2 Localization and the Estrogen Receptor Cistrome in ER+/HER2+ Breast Cancer
- Patterns of central nervous system and leptomeningeal involvement in advanced breast cancer with invasive lobular histology: a large multicenter study with a focus on estrogen receptor-positive/HER2-negative disease
BibTeX
@article{anon2026selective,
title = {{Selective estrogen receptor degraders and their effect on the breast cancer immune microenvironment}},
journal = {The Journal of clinical investigation},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13668616},
note = {CC BY},
}
RIS
TY - JOUR
TI - Selective estrogen receptor degraders and their effect on the breast cancer immune microenvironment
PY - 2026
DA - 2026/10/19
JO - The Journal of clinical investigation
UR - https://europepmc.org/article/PMC/PMC13668616
SN - 0021-9738
SN - 1558-8238
ER -